Harold Leever Regional Cancer Center
Waterbury, Connecticut, United States
Cancer treatment center in Waterbury, Connecticut
1075 Chase Pkwy, Waterbury, CT 06708
About Harold Leever Regional Cancer Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
4
Daiichi Sankyo, Inc.
1
NSABP Foundation Inc
1
Synta Pharmaceuticals Corp.
1
Clinical Trials at Harold Leever Regional Cancer Center
During the past decade, Harold Leever Regional Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Soblidotin in Treating Patients With Progressive Locally Advanced or Metastatic Non-Small Cell Lung Cancer
2003-04-01
2005-05-01
Completed
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
2006-04-07
2030-09-30
Active, not recruiting
10,273
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
2007-06-01
2023-10-16
Active, not recruiting
1,501
Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
2006-08-01
2023-12-01
Active, not recruiting
3,966
Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive
2006-09-15
2014-07-02
Completed
295
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
2011-01-15
2024-03-07
Active, not recruiting
5,083
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Harold Leever Regional Cancer Center"
#1 collaborator was "Cancer and Leukemia Group B" with 2 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator, "North Central Cancer Treatment Group" with 2 trials as a collaborator, "SWOG Cancer Research Network" with 2 trials as a collaborator and "American College of Surgeons" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 8 trials.
Clinical Trials Conditions at Harold Leever Regional Cancer Center
According to Clinical.Site data, the most researched conditions in "Harold Leever Regional Cancer Center" are
"Stage IIIB Breast Cancer AJCC v7" (2 trials), "Breast Adenocarcinoma" (1 trials), "Breast Cancer" (1 trials), "Breast Ductal Carcinoma In Situ" (1 trials) and "Estrogen Receptor Positive" (1 trials). Many other conditions were trialed in "Harold Leever Regional Cancer Center" in a lesser frequency.
Clinical Trials Intervention Types at Harold Leever Regional Cancer Center
Most popular intervention types in "Harold Leever Regional Cancer Center" are "Drug" (7 trials), "Other" (5 trials), "Biological" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (4 trials), "Letrozole" (3 trials), "Anastrozole" (2 trials), "Exemestane" (2 trials) and "Quality-of-Life Assessment" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Harold Leever Regional Cancer Center
The vast majority of trials in "Harold Leever Regional Cancer Center" are
4 trials for "Female" genders and 3 trials for "All" genders.
Clinical Trials Status at Harold Leever Regional Cancer Center
Currently, there are NaN active trials in "Harold Leever Regional Cancer Center".
undefined are not yet recruiting,
undefined are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Harold Leever Regional Cancer Center,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Harold Leever Regional Cancer Center, 1 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".